Myeloid-derived suppressor cell heterogeneity in human cancers - PubMed (original) (raw)
Review
Myeloid-derived suppressor cell heterogeneity in human cancers
Samantha Solito et al. Ann N Y Acad Sci. 2014 Jun.
Abstract
The dynamic interplay between cancer and host immune system often affects the process of myelopoiesis. As a consequence, tumor-derived factors sustain the accumulation and functional differentiation of myeloid cells, including myeloid-derived suppressor cells (MDSCs), which can interfere with T cell-mediated responses. Since both the phenotype and mechanisms of action of MDSCs appear to be tumor-dependent, it is important not only to determine the presence of all MDSC subsets in each cancer patient, but also which MDSC subsets have clinical relevance in each tumor environment. In this review, we describe the differences between MDSC populations expanded within different tumor contexts and evaluate the prognostic significance of MDSC expansion in peripheral blood and within tumor masses of neoplastic patients.
Keywords: MDSCs; T cells; cancer; immunosuppression; innate immunity; myeloid-derived suppressor cells; tumors.
© 2014 New York Academy of Sciences.
Similar articles
- Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A. Schlecker E, et al. J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14. J Immunol. 2012. PMID: 23152559 - Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E, Mommer C, Movahedi K, Laoui D, Morias Y, Gysemans C, Luyckx A, De Baetselier P, Van Ginderachter JA. Schouppe E, et al. Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25. Eur J Immunol. 2013. PMID: 23878002 - Myeloid-derived suppressor cells in cancer: recent progress and prospects.
Khaled YS, Ammori BJ, Elkord E. Khaled YS, et al. Immunol Cell Biol. 2013 Sep;91(8):493-502. doi: 10.1038/icb.2013.29. Epub 2013 Jun 25. Immunol Cell Biol. 2013. PMID: 23797066 Review. - Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T, Mahnke K, Enk AH. Fujimura T, et al. J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001. J Dermatol Sci. 2010. PMID: 20570112 Review. - Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X. Yu J, et al. J Immunol. 2013 Apr 1;190(7):3783-97. doi: 10.4049/jimmunol.1201449. Epub 2013 Feb 25. J Immunol. 2013. PMID: 23440412
Cited by
- Innate Immune Cells in Melanoma: Implications for Immunotherapy.
Trocchia M, Ventrici A, Modestino L, Cristinziano L, Ferrara AL, Palestra F, Loffredo S, Capone M, Madonna G, Romanelli M, Ascierto PA, Galdiero MR. Trocchia M, et al. Int J Mol Sci. 2024 Aug 5;25(15):8523. doi: 10.3390/ijms25158523. Int J Mol Sci. 2024. PMID: 39126091 Free PMC article. Review. - Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y. Lin H, et al. J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7. J Hematol Oncol. 2024. PMID: 38720342 Free PMC article. Review. - Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells.
Tamuli B, Sharma S, Patkar M, Biswas S. Tamuli B, et al. Cancer Rep (Hoboken). 2024 May;7(5):e2066. doi: 10.1002/cnr2.2066. Cancer Rep (Hoboken). 2024. PMID: 38703051 Free PMC article. Review. - The immunosuppressive landscape in tumor microenvironment.
Liu W, Zhou H, Lai W, Hu C, Xu R, Gu P, Luo M, Zhang R, Li G. Liu W, et al. Immunol Res. 2024 Aug;72(4):566-582. doi: 10.1007/s12026-024-09483-8. Epub 2024 May 1. Immunol Res. 2024. PMID: 38691319 Review. - Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-Guérin Immunotherapy of Bladder Cancer.
Ibrahim OM, Kalinski P. Ibrahim OM, et al. Cells. 2024 Apr 18;13(8):699. doi: 10.3390/cells13080699. Cells. 2024. PMID: 38667314 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials